Izumi et al. validated its use for early-stage GC diagnosis in a prospective study (49), and Modlin et al. demonstrated that multigenomic liquid biopsy markers outperform traditional markers like CgA in neuroendocrine tumours, suggesting relevance in GC (50). The gene discussed is CGA; the disease is gastric cancer.